Agenda/Scientific Program

Keynote Speaker

Image of female wearing glasses and text 'Bioassays 2023 Keynote Speaker Helena Madden bluebird bio, inc.'Helena Madden is a Senior Director of CMC Regulatory Affairs at bluebird bio where she oversees life cycle management of bluebird’s commercial gene therapy products. Prior to joining bluebird Helena worked for 19 years at Biogen leading the Regulatory CMC aspects of Biogen’s products in Japan and previously directing Biogen’s Analytical Development (AD) team. In AD she was responsible for establishing a process-related impurity method development group and a bioassay development group. Before joining Biogen, Helena worked for Oncogene Research products where she developed bioassays, immunoassays and various apoptosis methods.

Helena holds a Ph.D. in Biochemistry from Boston University School of Medicine and a B.S. in Medical Technology from Northeastern University. She has extensive experience in hematology and cell differentiation from her post-doctoral training at Harvard Medical School / Deaconess Hospital.

Workshop: Potency Assay Strategies for Biopharmaceuticals and for CGT Therapeutics

April 17, 2023 | 13:00 – 17:00 EDT
Facilitators: Michael Sadick, Precision Biosciences and Jyoti Velayudhan, Seagen Inc.

The Bioassays Potency Workshop will review the following: What questions does a potency assay address? What is required for a well controlled potency assay? and more. 

View Workshop Information

Register Now

Join us in-person for Bioassays 2023 on April 17-19, 2023. Registration will close March 31, 2023

Image of purple background with text 'Bioassays Scientific Approaches and Regulatory Strategies 2023 April 17-19 Gaithersburg, MD'

Engage with Exhibitors

Bioassays 2023 is giving you a wide range of opportunities to engage with exhibitors.

There are multiple ways to connect with our partners before and during the Symposium to learn more about how their products can better serve you.

View Opportunities